ID   CATE_HUMAN              Reviewed;         401 AA.
AC   P14091; Q5TZ01; Q5TZ02; Q9NY58; Q9UCE3; Q9UCE4;
DT   01-JAN-1990, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2004, sequence version 2.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=Cathepsin E;
DE            EC=3.4.23.34;
DE   Contains:
DE     RecName: Full=Cathepsin E form I;
DE   Contains:
DE     RecName: Full=Cathepsin E form II;
DE   Flags: Precursor;
GN   Name=CTSE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Gastric mucosa;
RX   PubMed=2674141;
RA   Azuma T., Pals G., Mohandas T.K., Couvreur J.M., Taggart R.T.;
RT   "Human gastric cathepsin E. Predicted sequence, localization to
RT   chromosome 1, and sequence homology with other aspartic proteinases.";
RL   J. Biol. Chem. 264:16748-16753(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=1370478;
RA   Azuma T., Liu W.G., Vander Laan D.J., Bowcock A.M., Taggart R.T.;
RT   "Human gastric cathepsin E gene. Multiple transcripts result from
RT   alternative polyadenylation of the primary transcripts of a single
RT   gene locus at 1q31-q32.";
RL   J. Biol. Chem. 267:1609-1614(1992).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3), SUBCELLULAR LOCATION,
RP   AND GLYCOSYLATION.
RC   TISSUE=Intestine;
RX   PubMed=7983070;
RA   Finley E.M., Kornfeld S.;
RT   "Subcellular localization and targeting of cathepsin E.";
RL   J. Biol. Chem. 269:31259-31266(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Gastric adenocarcinoma;
RX   PubMed=12531480; DOI=10.1016/S0167-4781(02)00595-X;
RA   Tatnell P.J., Cook M., Kay J.;
RT   "An alternatively spliced variant of cathepsin E in human gastric
RT   adenocarcinoma cells.";
RL   Biochim. Biophys. Acta 1625:203-206(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Stomach;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 20-38 AND 54-76, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AUTOCATALYTIC CLEAVAGE, AND GLYCOSYLATION.
RC   TISSUE=Erythrocyte;
RX   PubMed=8346912; DOI=10.1006/abbi.1993.1361;
RA   Takeda-Ezaki M., Yamamoto K.;
RT   "Isolation and biochemical characterization of procathepsin E from
RT   human erythrocyte membranes.";
RL   Arch. Biochem. Biophys. 304:352-358(1993).
RN   [10]
RP   PROTEIN SEQUENCE OF 54-68; 77-95; 141-154; 280-290 AND 394-401, AND
RP   GLYCOSYLATION.
RC   TISSUE=Gastric mucosa;
RX   PubMed=2334440; DOI=10.1016/0006-291X(90)92403-M;
RA   Athauda S.B.P., Matsuzaki O., Kgeyama T., Takahashi K.;
RT   "Structural evidence for two isozymic forms and the carbohydrate
RT   attachment site of human gastric cathepsin E.";
RL   Biochem. Biophys. Res. Commun. 168:878-885(1990).
RN   [11]
RP   CATALYTIC ACTIVITY, SUBUNIT, DISULFIDE BONDS, AND MUTAGENESIS OF
RP   CYS-60.
RX   PubMed=7789521; DOI=10.1016/0014-5793(95)00501-Y;
RA   Fowler S.D., Kay J., Dunn B.M., Tatnell P.J.;
RT   "Monomeric human cathepsin E.";
RL   FEBS Lett. 366:72-74(1995).
RN   [12]
RP   FUNCTION, CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=8765029; DOI=10.1002/eji.1830260826;
RA   Sealy L., Mota F., Rayment N., Tatnell P.J., Kay J., Chain B.;
RT   "Regulation of cathepsin E expression during human B cell
RT   differentiation in vitro.";
RL   Eur. J. Immunol. 26:1838-1843(1996).
RN   [13]
RP   TISSUE SPECIFICITY.
RX   PubMed=11322887; DOI=10.1046/j.1432-1327.2001.02159.x;
RA   Cook M., Caswell R.C., Richards R.J., Kay J., Tatnell P.J.;
RT   "Regulation of human and mouse procathepsin E gene expression.";
RL   Eur. J. Biochem. 268:2658-2668(2001).
CC   -!- FUNCTION: May have a role in immune function. Probably involved in
CC       the processing of antigenic peptides during MHC class II-mediated
CC       antigen presentation. May play a role in activation-induced
CC       lymphocyte depletion in the thymus, and in neuronal degeneration
CC       and glial cell activation in the brain.
CC       {ECO:0000269|PubMed:8765029}.
CC   -!- CATALYTIC ACTIVITY: Similar to cathepsin D, but slightly broader
CC       specificity. {ECO:0000269|PubMed:7789521,
CC       ECO:0000269|PubMed:8765029}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.06 mM for hemoglobin {ECO:0000269|PubMed:8346912};
CC         KM=0.13 mM for Pro-Pro-Thr-Ile-Phe-Phe(4-NO2)-Arg-Leu
CC         {ECO:0000269|PubMed:8346912};
CC         KM=0.04 mM for Lys-Pro-Ile-Glu-Phe-Phe(4-NO2)-Arg-Leu
CC         {ECO:0000269|PubMed:8346912};
CC   -!- SUBUNIT: Homodimer; disulfide-linked.
CC       {ECO:0000269|PubMed:7789521}.
CC   -!- SUBCELLULAR LOCATION: Endosome {ECO:0000269|PubMed:7983070}.
CC       Note=The proenzyme is localized to the endoplasmic reticulum and
CC       Golgi apparatus, while the mature enzyme is localized to the
CC       endosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=P14091-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=P14091-1; Sequence=VSP_009729;
CC       Name=2;
CC         IsoId=P14091-2; Sequence=VSP_009729, VSP_009730, VSP_009731;
CC   -!- TISSUE SPECIFICITY: Expressed abundantly in the stomach, the Clara
CC       cells of the lung and activated B-lymphocytes, and at lower levels
CC       in lymph nodes, skin and spleen. Not expressed in resting B-
CC       lymphocytes. {ECO:0000269|PubMed:11322887,
CC       ECO:0000269|PubMed:1370478, ECO:0000269|PubMed:8765029}.
CC   -!- PTM: Glycosylated. The nature of the carbohydrate chain varies
CC       between cell types. In fibroblasts, the proenzyme contains a high
CC       mannose-type oligosaccharide, while the mature enzyme contains a
CC       complex-type oligosaccharide. In erythrocyte membranes, both the
CC       proenzyme and mature enzyme contain a complex-type
CC       oligosaccharide. {ECO:0000269|PubMed:2334440,
CC       ECO:0000269|PubMed:7983070, ECO:0000269|PubMed:8346912}.
CC   -!- PTM: Two forms are produced by autocatalytic cleavage, form I
CC       begins at Ile-54, form II begins at Thr-57.
CC   -!- SIMILARITY: Belongs to the peptidase A1 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; J05036; AAA52130.1; -; mRNA.
DR   EMBL; M84424; AAA52300.1; -; Genomic_DNA.
DR   EMBL; M84413; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84417; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84418; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84419; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84420; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84421; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; M84422; AAA52300.1; JOINED; Genomic_DNA.
DR   EMBL; AJ250716; CAB82849.1; -; mRNA.
DR   EMBL; AJ250717; CAB82850.1; -; mRNA.
DR   EMBL; AK292057; BAF84746.1; -; mRNA.
DR   EMBL; BX571818; CAH73264.1; -; Genomic_DNA.
DR   EMBL; BX571818; CAH73265.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91592.1; -; Genomic_DNA.
DR   EMBL; CH471067; EAW91593.1; -; Genomic_DNA.
DR   EMBL; BC042537; AAH42537.1; -; mRNA.
DR   CCDS; CCDS73012.1; -. [P14091-2]
DR   CCDS; CCDS73013.1; -. [P14091-1]
DR   PIR; A42038; A34401.
DR   RefSeq; NP_001304260.1; NM_001317331.1.
DR   RefSeq; NP_001901.1; NM_001910.3. [P14091-1]
DR   RefSeq; NP_683865.1; NM_148964.2. [P14091-2]
DR   UniGene; Hs.644082; -.
DR   PDB; 1LCG; Model; -; A=1-401.
DR   PDB; 1TZS; X-ray; 2.35 A; A=54-401, P=19-53.
DR   PDBsum; 1LCG; -.
DR   PDBsum; 1TZS; -.
DR   ProteinModelPortal; P14091; -.
DR   SMR; P14091; -.
DR   BioGrid; 107890; 8.
DR   IntAct; P14091; 2.
DR   MINT; MINT-1388890; -.
DR   STRING; 9606.ENSP00000350911; -.
DR   BindingDB; P14091; -.
DR   ChEMBL; CHEMBL3092; -.
DR   GuidetoPHARMACOLOGY; 2346; -.
DR   MEROPS; A01.010; -.
DR   iPTMnet; P14091; -.
DR   PhosphoSitePlus; P14091; -.
DR   BioMuta; CTSE; -.
DR   DMDM; 46397366; -.
DR   PaxDb; P14091; -.
DR   PeptideAtlas; P14091; -.
DR   PRIDE; P14091; -.
DR   DNASU; 1510; -.
DR   Ensembl; ENST00000358184; ENSP00000350911; ENSG00000196188. [P14091-1]
DR   Ensembl; ENST00000360218; ENSP00000353350; ENSG00000196188. [P14091-2]
DR   GeneID; 1510; -.
DR   KEGG; hsa:1510; -.
DR   UCSC; uc001hdu.3; human. [P14091-3]
DR   CTD; 1510; -.
DR   DisGeNET; 1510; -.
DR   GeneCards; CTSE; -.
DR   HGNC; HGNC:2530; CTSE.
DR   HPA; CAB032687; -.
DR   HPA; HPA012940; -.
DR   MIM; 116890; gene.
DR   neXtProt; NX_P14091; -.
DR   OpenTargets; ENSG00000196188; -.
DR   PharmGKB; PA27030; -.
DR   eggNOG; KOG1339; Eukaryota.
DR   eggNOG; ENOG410XNV7; LUCA.
DR   GeneTree; ENSGT00760000118929; -.
DR   HOGENOM; HOG000197681; -.
DR   HOVERGEN; HBG000482; -.
DR   InParanoid; P14091; -.
DR   KO; K01382; -.
DR   OMA; GEYAMEC; -.
DR   OrthoDB; EOG091G0JP7; -.
DR   PhylomeDB; P14091; -.
DR   TreeFam; TF314990; -.
DR   BRENDA; 3.4.23.34; 2681.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   SABIO-RK; P14091; -.
DR   EvolutionaryTrace; P14091; -.
DR   GeneWiki; Cathepsin_E; -.
DR   GenomeRNAi; 1510; -.
DR   PMAP-CutDB; P14091; -.
DR   PRO; PR:P14091; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000196188; -.
DR   CleanEx; HS_CTSE; -.
DR   Genevisible; P14091; HS.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0004190; F:aspartic-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; IDA:UniProtKB.
DR   GO; GO:0007586; P:digestion; TAS:ProtInc.
DR   GO; GO:0016540; P:protein autoprocessing; IEA:Ensembl.
DR   GO; GO:0030163; P:protein catabolic process; IBA:GO_Central.
DR   Gene3D; 2.40.70.10; -; 2.
DR   InterPro; IPR001461; Aspartic_peptidase_A1.
DR   InterPro; IPR001969; Aspartic_peptidase_AS.
DR   InterPro; IPR012848; Aspartic_peptidase_N.
DR   InterPro; IPR033145; Cathepsin_E.
DR   InterPro; IPR033121; PEPTIDASE_A1.
DR   InterPro; IPR021109; Peptidase_aspartic_dom.
DR   PANTHER; PTHR13683; PTHR13683; 1.
DR   PANTHER; PTHR13683:SF388; PTHR13683:SF388; 1.
DR   Pfam; PF07966; A1_Propeptide; 1.
DR   Pfam; PF00026; Asp; 1.
DR   PRINTS; PR00792; PEPSIN.
DR   SUPFAM; SSF50630; SSF50630; 1.
DR   PROSITE; PS00141; ASP_PROTEASE; 2.
DR   PROSITE; PS51767; PEPTIDASE_A1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Aspartyl protease;
KW   Autocatalytic cleavage; Complete proteome; Direct protein sequencing;
KW   Disulfide bond; Endosome; Glycoprotein; Hydrolase; Polymorphism;
KW   Protease; Reference proteome; Signal; Zymogen.
FT   SIGNAL        1     19       {ECO:0000269|PubMed:8346912}.
FT   PROPEP       20     53       Activation peptide.
FT                                {ECO:0000269|PubMed:2334440,
FT                                ECO:0000269|PubMed:8346912}.
FT                                /FTId=PRO_0000025974.
FT   CHAIN        54    401       Cathepsin E form I.
FT                                /FTId=PRO_0000025975.
FT   CHAIN        57    401       Cathepsin E form II.
FT                                /FTId=PRO_0000354668.
FT   DOMAIN       78    397       Peptidase A1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01103}.
FT   ACT_SITE     96     96       {ECO:0000255|PROSITE-ProRule:PRU10094}.
FT   ACT_SITE    286    286       {ECO:0000255|PROSITE-ProRule:PRU10094}.
FT   CARBOHYD     90     90       N-linked (GlcNAc...) asparagine.
FT   DISULFID     60     60       Interchain. {ECO:0000269|PubMed:7789521}.
FT   DISULFID    109    114       {ECO:0000250}.
FT   DISULFID    277    281       {ECO:0000250}.
FT   DISULFID    319    356       {ECO:0000250}.
FT   VAR_SEQ     155    159       Missing (in isoform 1 and isoform 2).
FT                                {ECO:0000303|PubMed:12531480,
FT                                ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:2674141,
FT                                ECO:0000303|PubMed:7983070}.
FT                                /FTId=VSP_009729.
FT   VAR_SEQ     268    368       IQVGGTVMFCSEGCQAIVDTGTSLITGPSDKIKQLQNAIGA
FT                                APVDGEYAVECANLNVMPDVTFTINGVPYTLSPTAYTLLDF
FT                                VDGMQFCSSGFQGLDIHPP -> MLWSVPTLTSCRMSPSPL
FT                                TESPIPSAQLPTPYWTSWMECSSAAVAFKDLTSTLQLGPSG
FT                                SWGMSSFDSFTQSLTVGITVWDWPQQSPKEGPCVCACLSDR
FT                                P (in isoform 2).
FT                                {ECO:0000303|PubMed:12531480,
FT                                ECO:0000303|PubMed:2674141}.
FT                                /FTId=VSP_009730.
FT   VAR_SEQ     369    401       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:12531480,
FT                                ECO:0000303|PubMed:2674141}.
FT                                /FTId=VSP_009731.
FT   VARIANT      82     82       I -> V (in dbSNP:rs57621203).
FT                                /FTId=VAR_061731.
FT   VARIANT     329    329       T -> I (in dbSNP:rs6503).
FT                                /FTId=VAR_014572.
FT   MUTAGEN      60     60       C->A: Abolishes homodimerization.
FT                                {ECO:0000269|PubMed:7789521}.
FT   STRAND       22     25       {ECO:0000244|PDB:1TZS}.
FT   HELIX        71     73       {ECO:0000244|PDB:1TZS}.
FT   STRAND       74     76       {ECO:0000244|PDB:1TZS}.
FT   STRAND       79     84       {ECO:0000244|PDB:1TZS}.
FT   TURN         85     88       {ECO:0000244|PDB:1TZS}.
FT   STRAND       89     96       {ECO:0000244|PDB:1TZS}.
FT   STRAND      102    106       {ECO:0000244|PDB:1TZS}.
FT   HELIX       112    114       {ECO:0000244|PDB:1TZS}.
FT   HELIX       122    124       {ECO:0000244|PDB:1TZS}.
FT   STRAND      134    141       {ECO:0000244|PDB:1TZS}.
FT   STRAND      143    154       {ECO:0000244|PDB:1TZS}.
FT   STRAND      163    173       {ECO:0000244|PDB:1TZS}.
FT   HELIX       179    183       {ECO:0000244|PDB:1TZS}.
FT   STRAND      187    191       {ECO:0000244|PDB:1TZS}.
FT   HELIX       195    197       {ECO:0000244|PDB:1TZS}.
FT   HELIX       199    201       {ECO:0000244|PDB:1TZS}.
FT   HELIX       205    211       {ECO:0000244|PDB:1TZS}.
FT   STRAND      216    223       {ECO:0000244|PDB:1TZS}.
FT   STRAND      235    238       {ECO:0000244|PDB:1TZS}.
FT   HELIX       243    245       {ECO:0000244|PDB:1TZS}.
FT   STRAND      251    254       {ECO:0000244|PDB:1TZS}.
FT   TURN        258    261       {ECO:0000244|PDB:1TZS}.
FT   STRAND      262    270       {ECO:0000244|PDB:1TZS}.
FT   STRAND      273    276       {ECO:0000244|PDB:1TZS}.
FT   STRAND      281    285       {ECO:0000244|PDB:1TZS}.
FT   STRAND      290    294       {ECO:0000244|PDB:1TZS}.
FT   HELIX       296    306       {ECO:0000244|PDB:1TZS}.
FT   STRAND      312    317       {ECO:0000244|PDB:1TZS}.
FT   HELIX       319    324       {ECO:0000244|PDB:1TZS}.
FT   STRAND      328    332       {ECO:0000244|PDB:1TZS}.
FT   STRAND      335    339       {ECO:0000244|PDB:1TZS}.
FT   TURN        341    343       {ECO:0000244|PDB:1TZS}.
FT   STRAND      344    346       {ECO:0000244|PDB:1TZS}.
FT   STRAND      356    362       {ECO:0000244|PDB:1TZS}.
FT   TURN        367    369       {ECO:0000244|PDB:1TZS}.
FT   STRAND      373    375       {ECO:0000244|PDB:1TZS}.
FT   HELIX       377    382       {ECO:0000244|PDB:1TZS}.
FT   STRAND      383    388       {ECO:0000244|PDB:1TZS}.
FT   TURN        389    392       {ECO:0000244|PDB:1TZS}.
FT   STRAND      393    399       {ECO:0000244|PDB:1TZS}.
SQ   SEQUENCE   401 AA;  43312 MW;  46A2BA35266032CB CRC64;
     MKTLLLLLLV LLELGEAQGS LHRVPLRRHP SLKKKLRARS QLSEFWKSHN LDMIQFTESC
     SMDQSAKEPL INYLDMEYFG TISIGSPPQN FTVIFDTGSS NLWVPSVYCT SPACKTHSRF
     QPSQSSTYSQ PGQSFSIQYG TGSLSGIIGA DQVSAFATQV EGLTVVGQQF GESVTEPGQT
     FVDAEFDGIL GLGYPSLAVG GVTPVFDNMM AQNLVDLPMF SVYMSSNPEG GAGSELIFGG
     YDHSHFSGSL NWVPVTKQAY WQIALDNIQV GGTVMFCSEG CQAIVDTGTS LITGPSDKIK
     QLQNAIGAAP VDGEYAVECA NLNVMPDVTF TINGVPYTLS PTAYTLLDFV DGMQFCSSGF
     QGLDIHPPAG PLWILGDVFI RQFYSVFDRG NNRVGLAPAV P
//
